Coll De Lima Hutchison
Biographic Data
| ID | 1250948 |
|---|---|
| NAME | Coll De Lima Hutchison |
| GIVEN NAMES | Coll De Lima |
| FAMILY NAME | Hutchison |
| SIGNATURE | HUTCHISON C L |
| AFFILIATIONS | London School of Hygiene & Tropical Medicine |
| ORCID | 0000-0002-0065-6507 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 3 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Sustaining (Dis)Embodied Inequalities in the(ir) Eurocene
Racialisation and colonialism are central to sustaining (dis)embodied inequalities. We bring together our distinct ethnographic projects to explore this. The first project accompanied a microbiome expedition involving Amazonian Indigenous non/human communities, whereas the second project focussed on medical professional’ encounters with Mbya Guarani communities in the Atlantic Forest region. Both projects explore racialised assumptions of human d…
Wars and sweets
Once upon a time, many of us moderns dreamt that our future was bright, squeaky clean, germ-free. Now, we increasingly fear that bacterial resistance movements and hordes of viruses are cancelling our medicated performances, and threatening life as many of us have come to know it. In order for our modern antibiotic theatre of war to go on, we pray for salvation through our intensive surveillance of microbes, crusades for more rational antibiotic …
Seeing Green
Medical professionals' and policymakers' fear of antimicrobial resistance (AMR) has largely been directed toward antibiotic use in medicine and animal agriculture. In Thailand, however, the use of antibiotics in citrus orchards has raised some concern over their 'appropriateness' and there have been calls for reduction-if not complete cessation-of their usage. We explore the emergence of antibiotic use for citrus greening disease (CGD) as part of…
Antibiotic stories
BACKGROUND: As concerns about the prevalence of infections that are resistant to available antibiotics increase, attention has turned toward the use of these medicines both within and outside of formal healthcare settings. Much of what is known about use beyond formal settings is informed by survey-based research. Few studies to date have used comparative, mixed-methods approaches to render visible patterns of use within and between settings as w…
Negotiating authoritarian law and (dis)order
Global health policymakers have identified Myanmar as a source of high drug resistance and informal pharmaceutical markets in need of tighter state regulation. The World Health Organization drafted a Global Action Plan on antibiotic resistance (often referred to as antimicrobial resistance) that seeks to address it. Myanmar is one of over a hundred countries that has followed the World Health Organization’s prescription and drafted its own Nation…
The ‘Drug Bag’ method
Understanding the prevalence and types of antibiotics used in a given human and/or animal population is important for informing stewardship strategies. Methods used to capture such data often rely on verbal elicitation of reported use that tend to assume shared medical terminology. Studies have shown the category 'antibiotic' does not translate well linguistically or conceptually, which limits the accuracy of these reports. This article presents …
Financial barriers and coping strategies
Financial constraints were identified by TB and MDR-TB patients and health care professionals as the most pervasive barrier to care. Barriers appeared to be magnified for ethnic minorities and patients coming from rural areas, especially those with MDR-TB. To reduce financial barriers and improve treatment outcomes, there is a need for further research into the total costs of seeking and accessing TB and MDR-TB care. This will enable better asses…
Are global tuberculosis control targets overlooking an essential indicator? Prolonged delays to diagnosis despite high case detection rates in Yunnan, China
Delay in treating active tuberculosis (TB) impedes disease control by allowing ongoing transmission, and may explain the unexpectedly modest declines in global TB incidence. Even though China has achieved TB control targets under the global Directly Observed Treatment, Short course (DOTS) strategy, TB prevalence in western provinces, including Yunnan, is not decreasing. This cross-sectional study investigates whether prolonged delay in identifyin…
Preventing emergence of drug resistant tuberculosis in Myanmar's transitioning health system
Multidrug-resistant tuberculosis (MDR-TB) is a particular threat to the populations of resource-limited countries. Although inadequate treatment of TB has been identified as a major underlying cause of drug resistance, essential information to inform changes in health service delivery and policy is missing. We investigate factors that may be driving the emergence of MDR-TB in Myanmar, a country where investment and health system reforms are ongoi…
Wars and sweets
Once upon a time, many of us moderns dreamt that our future was bright, squeaky clean, germ-free. Now, we increasingly fear that bacterial resistance movements and hordes of viruses are cancelling our medicated performances, and threatening life as many of us have come to know it. In order for our modern antibiotic theatre of war to go on, we pray for salvation through our intensive surveillance of microbes, crusades for more rational antibiotic …
Sustaining (Dis)Embodied Inequalities in the(ir) Eurocene
Racialisation and colonialism are central to sustaining (dis)embodied inequalities. We bring together our distinct ethnographic projects to explore this. The first project accompanied a microbiome expedition involving Amazonian Indigenous non/human communities, whereas the second project focussed on medical professional’ encounters with Mbya Guarani communities in the Atlantic Forest region. Both projects explore racialised assumptions of human d…
Financial barriers and coping strategies
Financial constraints were identified by TB and MDR-TB patients and health care professionals as the most pervasive barrier to care. Barriers appeared to be magnified for ethnic minorities and patients coming from rural areas, especially those with MDR-TB. To reduce financial barriers and improve treatment outcomes, there is a need for further research into the total costs of seeking and accessing TB and MDR-TB care. This will enable better asses…
Are global tuberculosis control targets overlooking an essential indicator? Prolonged delays to diagnosis despite high case detection rates in Yunnan, China
Delay in treating active tuberculosis (TB) impedes disease control by allowing ongoing transmission, and may explain the unexpectedly modest declines in global TB incidence. Even though China has achieved TB control targets under the global Directly Observed Treatment, Short course (DOTS) strategy, TB prevalence in western provinces, including Yunnan, is not decreasing. This cross-sectional study investigates whether prolonged delay in identifyin…
Preventing emergence of drug resistant tuberculosis in Myanmar's transitioning health system
Multidrug-resistant tuberculosis (MDR-TB) is a particular threat to the populations of resource-limited countries. Although inadequate treatment of TB has been identified as a major underlying cause of drug resistance, essential information to inform changes in health service delivery and policy is missing. We investigate factors that may be driving the emergence of MDR-TB in Myanmar, a country where investment and health system reforms are ongoi…
The ‘Drug Bag’ method
Understanding the prevalence and types of antibiotics used in a given human and/or animal population is important for informing stewardship strategies. Methods used to capture such data often rely on verbal elicitation of reported use that tend to assume shared medical terminology. Studies have shown the category 'antibiotic' does not translate well linguistically or conceptually, which limits the accuracy of these reports. This article presents …
Antibiotic stories
BACKGROUND: As concerns about the prevalence of infections that are resistant to available antibiotics increase, attention has turned toward the use of these medicines both within and outside of formal healthcare settings. Much of what is known about use beyond formal settings is informed by survey-based research. Few studies to date have used comparative, mixed-methods approaches to render visible patterns of use within and between settings as w…
Negotiating authoritarian law and (dis)order
Global health policymakers have identified Myanmar as a source of high drug resistance and informal pharmaceutical markets in need of tighter state regulation. The World Health Organization drafted a Global Action Plan on antibiotic resistance (often referred to as antimicrobial resistance) that seeks to address it. Myanmar is one of over a hundred countries that has followed the World Health Organization’s prescription and drafted its own Nation…
Wars and sweets
Once upon a time, many of us moderns dreamt that our future was bright, squeaky clean, germ-free. Now, we increasingly fear that bacterial resistance movements and hordes of viruses are cancelling our medicated performances, and threatening life as many of us have come to know it. In order for our modern antibiotic theatre of war to go on, we pray for salvation through our intensive surveillance of microbes, crusades for more rational antibiotic …
Seeing Green
Medical professionals' and policymakers' fear of antimicrobial resistance (AMR) has largely been directed toward antibiotic use in medicine and animal agriculture. In Thailand, however, the use of antibiotics in citrus orchards has raised some concern over their 'appropriateness' and there have been calls for reduction-if not complete cessation-of their usage. We explore the emergence of antibiotic use for citrus greening disease (CGD) as part of…
Sustaining (Dis)Embodied Inequalities in the(ir) Eurocene
Racialisation and colonialism are central to sustaining (dis)embodied inequalities. We bring together our distinct ethnographic projects to explore this. The first project accompanied a microbiome expedition involving Amazonian Indigenous non/human communities, whereas the second project focussed on medical professional’ encounters with Mbya Guarani communities in the Atlantic Forest region. Both projects explore racialised assumptions of human d…
Medicine (6 works) · Economic growth (4 works) · Environmental health (4 works) · Biology (3 works) · Political science (3 works) · Politics (3 works) · Population (3 works) · Sociology (3 works) · Tuberculosis (3 works) · Antibiotics (2 works)